Embed Size (px)
Citation preview
April 8, 2016Sky Song / Scottsdale
Regulatory and Reimbursement ObstaclesClinical Update of Molecular Diagnostics
ASU
Bruce Quinn MD PhDBruce . Quinn @ faegrebd . com323 839 8637 mobile
Digital Health & Genomics
Deck and White PaperAvailable…
Deck is available by emailWhite Paper is available by email
2
Up To Date: Y E S T E R D A Y (April 7)
3
Overview: The Impact of Dhealth on Genomics
Digital Health: $5B invested in CY2015►7% of all Venture Capital investment
Emerging Trends We Can Identify Now:
1) Genomic labs form networks with hospital centers2) New generation electronic networks connection patient,
doctor, EHR, genomics, clinical decision support3) EHR becomes “smart” in use of genomic data4) Mathematics, bioinformatics, modeling channel the utility of
genomic data
4
What does DHealth mean?
“Digital Health”►Positively… encompasses electronic health records, clinical decision support, remote monitoring, telemedicine, and “big data”► We can just say DHealth instead of 20 words and phrases
5
What does DHealth mean?
“Digital Health”►Positively… encompasses electronic health records, clinical decision support, remote monitoring, telemedicine, and “big data”► We can just say DHealth instead of 20 words and phrases
6
►Negatively… so broad a term as to be meaningless
ONEGenomic Labs Form Networks with Providers
►Foundation Medicine► Publicly held laboratory in Cambridge, MA► $500 Investment from Roche in 2015► “Precision Medicine Exchange Consortium”► Vanderbilt, Northwestern, Cleveland Clinic, Others
►Caris Life Sciences► Privately held laboratory here in Phoenix, AZ► Well capitalized► “Caris Centers of Excellence”► Fox Chase Cancer Center, Carolinas Health System, Wayne State,
Others
7
ONEGenomic Labs Form Networks with Providers
WHY?►Heavy investment required in training, familiarity, IT systems integration (LIMS, EHR)
►Create new consortia of cancer centers that can easily collaborate (clinical trials, etc)
►Market Lock‐In► Like frequent flier points, owning books on an Amazon Kindle► Less head to head competition with other labs IN RETURN FOR
smaller market of networked participantsOBSTACLES TO MANAGE►Compete with in‐house services at large medical centers►Still have to get “paid by payers”
8
TWONew complexity of active electronic interfaces
►Syapse► Palo Alto Startup► $25M new investment (Ascension Ventures)► Syapse Precision Medicine Platform► Not lab‐specific but has collaboration with Caris► “Cloud based software platform” genomics, clinical data,
pharmacy data, decision support. Supports TAPUR trial at ASCO.►Flatiron Health
► $130M from Google Health + $175M from Roche► Physician office support, dedicated to oncology, from payment
systems to (some) genomics support, “the new standard for oncology technology”
9
THREEEHR becomes SMART with Genomic Data
► AssureX, Genomind► Drug/gene analysis for psychiatry► NOT just a lab report of gene findings► Rather, provides drug‐specific reports
► Both services initially targeted neuropsychiatric drugs:► Difficult patients. Lots of drugs. Many choices. Many generic drugs.
► Genelex► Seattle Laboratory (> 10 years)► Remodeling itself; YouScript offering, API to interface with health
records and e‐Charts► NantHealth
► Los Angeles, $200M from Allscripts ($2B valuation) ► “EHR plus Genomics” and “Transformation of Care”
10
Physician Orders Genetics Report; Integrated Bioinformatics
11
Genetics
Databases
Ordering Physician
The Cutting Edge is Rapidly Moving…Genetics Integrated with Health System (YouScript)
12
Genetics
NetworkedPhysicians
Databases Pharmacist
EHR
DrugOrders
PharmaCompliance
Ordering Physician
FOURVery sophisticated virtual genomics
►IN SILICO ANALYSIS & THE FDA► This is a big deal for the FDA► National Workshop in November 2015► Next generation sequencing is not (generally) FDA‐approved now► Future pathways may piggyback on variant databases which
incorporate sophisticated software for variant calls
13
FOURVery sophisticated virtual genomics
► Cellworks► Silicon Valley startup, VC
funded► Predict likely effects of drug
libraries on “virtual cells” by using very sophisticated mathematical modeling
► Genepeeks► Virtual genetic software
added on top of parental or in vitro fertilization genomic test (e.g. screen collections of sperm donors)
14
► Massive Bio► NYC Startup► Virtual Tumor Board► “Precision Medicine Democratized”► Telemedicine meets information
management meets genomics► IBM Watson and Pathway Genomics
► Pathway has collectively had $130M investments
► Most recent investor = IBM Watson► Genomics & Wellness► See also: Google Verily & Dexcom
CONCLUSIONS
►A LOT IS GOING ON
►A LOT OF MONEY IS ENTERING THE SPACE
►THESE AND MORE COMPANIES ARE IN THIS SPACE
►IF YOU’RE STUCK ON “NEW CPT CODES” YOU’LL MISS THIS
15
IMPLICATIONS
►Changing industry structure, changing the boundaries of what it means to be “a genetics lab”
►Most of health system and payers will play catch‐up►Quantifying the healthcare value remains to be determined
Don’t ask:►“Does your lab have a medical app?”
►The important changes will be more like “sea changes”
16
Digital Health & Genomics
Deck and White PaperAvailable…
Deck is available by emailWhite Paper is available by email
[email protected]/digitalgenomicsbeta
Separate:Transcript of FDA Workshop on
Tumor Gene Panels February 2016www.tinyurl.com/fda20160220
17
